Johnson & Johnson Covid vaccine: EMA approves single-shot jab

Kobieta w maseczce chirurgicznej na twarzy trzymająca w dłoni strzykawkę podpisaną Covid-19 vaccine.

The European Medicines Agency approved another vaccine for the EU. The vaccine is set to be a cost-effective alternative to the Pfizer and Moderna vaccines, and can be stored in a refrigerator instead of a freezer and require only a single dose. Trials found it prevented serious illness but was 66% effective overall when moderate cases were included. The vaccine was developed mainly by J&J's Janssen Pharmaceutica division.